Cynthia X. Ma, MD of Washington University School of Medicine @WUSTLmed discusses neoadjuvant endocrine treatment (NET) approaches for clinical stage II or III estrogen receptor-positive HER2-negative breast cancer (ER+ HER2- BC) in postmenopausal (PM) women.
Cynthia X. Ma, MD on NET for Clinical Stage II or III ER+ HER2- BC: What Should be Used in Clinic? #ASCO2020 @WUSTLmed
By Editor